433 related articles for article (PubMed ID: 18208354)
1. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
3. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
5. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
[TBL] [Abstract][Full Text] [Related]
6. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
9. Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression.
Saxena A; Moshynska OV; Moshynskyy ID; Neuls ED; Qureshi T; Bosch M; Voralia M; Bonham K
Cancer Lett; 2007 Jun; 251(1):114-31. PubMed ID: 17198743
[TBL] [Abstract][Full Text] [Related]
10. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
12. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
13. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
14. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
15. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
16. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells.
Hantusch B; Kalt R; Krieger S; Puri C; Kerjaschki D
BMC Mol Biol; 2007 Mar; 8():20. PubMed ID: 17343736
[TBL] [Abstract][Full Text] [Related]
17. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
18. The gonadotropin-regulated long-chain acyl CoA synthetase gene: a novel downstream Sp1/Sp3 binding element critical for transcriptional promoter activity.
Sheng Y; Li J; Dufau ML; Tsai-Morris CH
Gene; 2005 Oct; 360(1):20-6. PubMed ID: 16125341
[TBL] [Abstract][Full Text] [Related]
19. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
Laenen K; Haegeman G; Vanhoenacker P
Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Boxer LM
Oncogene; 2002 May; 21(24):3898-908. PubMed ID: 12032828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
